Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
All Over-The-Counter (OTC) drug products warehoused Recalled by Inmar Supply Chain Solutions, LLC Due to CGMP Deviations: Potential exposure to rodents and rodent...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Inmar Supply Chain Solutions, LLC directly.
Affected Products
All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.
Quantity: Unknown
Why Was This Recalled?
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.
Where Was This Sold?
Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
About Inmar Supply Chain Solutions, LLC
Inmar Supply Chain Solutions, LLC has 3 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report